Recipharm races to India with Nitin

0
1628

Recipharm, a Swedish contract development and manufacturing organization in the pharmaceutical sector, has signed an agreement to purchase 74% of the shares Nitin Lifesciences, an Indian sterile injectables contract manufacturing company.

You must be a subscribersubscribersubscribersubscriber to read this content, please subscribesubscribesubscribesubscribe today.

你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章,欢迎成为我们的订阅会员成为我们的订阅会员